Sort by
Search results
CoaChrom™ Severe Abnormal Control Plasma
Severe Abnormal Control Plasma for the quality control of FVIII, FIX and vWF assays. For Research Use Only.
Tris NaCl EDTA Buffer with heparin neutralisation, pH 7.85
For testing direct FXa inhibitors, especially with BIOPHEN Heparin LRT (ref. 221011 / 221013 / 221015), BIOPHEN Heparin 3 (ref. 221003), BIOPHEN Heparin 6 (ref. 221006) or BIOPHEN DiXaI (ref. 221030). This buffer totally neutralizes heparin present in the assay sample and renders a measurement totally specific for DiXaI.
Tris NaCl EDTA Buffer with heparin neutralisation, pH 7.85
For testing direct FXa inhibitors, especially with BIOPHEN Heparin LRT (ref. 221011 / 221013 / 221015), BIOPHEN Heparin 3 (ref. 221003), BIOPHEN Heparin 6 (ref. 221006) or BIOPHEN DiXaI (ref. 221030). This buffer totally neutralizes heparin present in the assay sample and renders a measurement totally specific for DiXaI.
Factor IX deficient plasma congenital (frozen)
For all in-vitro -analyses that require congenital human factor IX deficient plasma.
HEPA-Remove®
Heparin and heparin-like molecules interfere with various assays including coagulation assays and PCR-based assays. HEPA-Remove ® has been designed to eliminate these interferences. Moreover, HEPA-Remove ® inhibits FXII activation in aPTT based assays. For research use only.
Donor Plasma with Vitamin K antagonists (Warfarin-Sodium, Coumadin)
For all in vitro analyses that require vitamin K antagonist plasma.
Emicizumab Controls
Quality control of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.
Emicizumab Calibrator
Calibration of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.
Protein C Epitope, anti-human mouse, IgG
Protein C epitope, anti-human mouse, IgG (monoclonal)
Human Antithrombin Neutralisation Set
Neutralisation of antithrombin in human plasma.